» Articles » PMID: 3600145

Plasma Levels of Ethionamide and Prothionamide in a Volunteer Following Intravenous and Oral Dosages

Overview
Journal Lepr Rev
Specialty Tropical Medicine
Date 1987 Mar 1
PMID 3600145
Citations 8
Authors
Affiliations
Soon will be listed here.
Citing Articles

Prothionamide Dose Optimization Using Population Pharmacokinetics for Multidrug-Resistant Tuberculosis Patients.

Yun H, Chang M, Jung H, Chang V, Wang Q, Strydom N Antimicrob Agents Chemother. 2022; 66(9):e0189321.

PMID: 35938799 PMC: 9487524. DOI: 10.1128/aac.01893-21.


MDR Tuberculosis Treatment.

Espinosa-Pereiro J, Sanchez-Montalva A, Aznar M, Espiau M Medicina (Kaunas). 2022; 58(2).

PMID: 35208510 PMC: 8878254. DOI: 10.3390/medicina58020188.


Population Pharmacokinetics and Dosing of Ethionamide in Children with Tuberculosis.

Bjugard Nyberg H, Draper H, Garcia-Prats A, Thee S, Bekker A, Zar H Antimicrob Agents Chemother. 2019; 64(3).

PMID: 31871093 PMC: 7038277. DOI: 10.1128/AAC.01984-19.


EthA/R-Independent Killing of by Ethionamide.

Ang M, Zainul Rahim S, de Sessions P, Lin W, Koh V, Pethe K Front Microbiol. 2017; 8:710.

PMID: 28487681 PMC: 5403819. DOI: 10.3389/fmicb.2017.00710.


An ethA-ethR-deficient Mycobacterium bovis BCG mutant displays increased adherence to mammalian cells and greater persistence in vivo, which correlate with altered mycolic acid composition.

Ang M, Zainul Rahim S, Siti Z, Shui G, Dianiskova P, Madacki J Infect Immun. 2014; 82(5):1850-9.

PMID: 24566628 PMC: 3993443. DOI: 10.1128/IAI.01332-13.